PCN11- ECONOMIC EVALUATION OF LIPOSOMAL DOXORUBICIN VS TOPOTECAN FOR RECURRENT OVARIAN CANCER IN THE UK
Sep 1, 2001, 00:00 AM
10.1046/j.1524-4733.2001.40202-57.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71216-5/fulltext
Section Title :
Section Order :
108
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71216-5&doi=10.1046/j.1524-4733.2001.40202-57.x